Published in Int J Cancer on March 20, 2001
Circulating tumour markers can define patients with normal colons, benign polyps, and cancers. Br J Cancer (2011) 1.30
The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells. Immunology (2005) 1.28
Release and activity of histone in diseases. Cell Death Dis (2014) 1.10
Docetaxel induces apoptosis in hormone refractory prostate carcinomas during multiple treatment cycles. Br J Cancer (2006) 1.06
Blood and tissue biomarkers in prostate cancer: state of the art. Urol Clin North Am (2010) 1.02
Plasmodium falciparum histones induce endothelial proinflammatory response and barrier dysfunction. Am J Pathol (2012) 1.01
Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy. BMC Cancer (2012) 0.94
Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment? World J Biol Chem (2015) 0.94
Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer. Clin Epigenetics (2015) 0.87
Serum cytokeratin 18 as a biomarker for gastric cancer. Clin Exp Med (2012) 0.87
Extracellular Histones Induce Chemokine Production in Whole Blood Ex Vivo and Leukocyte Recruitment In Vivo. PLoS Pathog (2015) 0.81
Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.79
Silver Nanoscale Hexagonal Column Chips for Detecting Cell-free DNA and Circulating Nucleosomes in Cancer Patients. Sci Rep (2015) 0.78
Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing. Transl Lung Cancer Res (2016) 0.78
Elevation of serum fortilin levels is specific for apoptosis and signifies cell death in vivo. BBA Clin (2014) 0.76
Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments. BMC Cancer (2006) 0.76
Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulation. Cell Death Dis (2016) 0.75
Neutrophil extracellular trap formation and circulating nucleosomes in patients with chronic myeloproliferative neoplasms. Sci Rep (2016) 0.75
Novel chemokine-like activities of histones in tumor metastasis. Oncotarget (2016) 0.75
Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer. Cancers (Basel) (2017) 0.75
Clinical Applications of Liquid Biopsies in Gastrointestinal Oncology. Gastrointest Cancer Res (2014) 0.75
Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance. BMC Cancer (2005) 0.75
A novel method for isolation of histones from serum and its implications in therapeutics and prognosis of solid tumours. Clin Epigenetics (2017) 0.75
Secretion of IFN-γ Associated with Galectin-9 Production by Pleural Fluid Cells from a Patient with Extrapulmonary Tuberculosis. Int J Mol Sci (2017) 0.75
The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med (1996) 5.56
Brucella abortus 16S rRNA and lipid A reveal a phylogenetic relationship with members of the alpha-2 subdivision of the class Proteobacteria. J Bacteriol (1990) 3.36
Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology (2000) 2.65
Low status control, high effort at work and ischemic heart disease: prospective evidence from blue-collar men. Soc Sci Med (1990) 2.63
Differences in the temporal trends of HIV seroincidence and seroprevalence among sexually transmitted disease clinic patients, 1989-1998: application of the serologic testing algorithm for recent HIV seroconversion. Am J Epidemiol (2001) 2.22
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol (2007) 2.05
Quality of care of VLBW neonates: relationship between unit volume and outcome is different between metropolitan and rural regions. Acta Paediatr (2008) 2.04
Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc Natl Acad Sci U S A (1984) 1.99
Antigen conformation determines processing requirements for T-cell activation. Proc Natl Acad Sci U S A (1984) 1.94
A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. J Clin Invest (1969) 1.93
The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis (1986) 1.85
Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group. Transplantation (2000) 1.84
Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma. Cancer Res (1995) 1.83
Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence. Aliment Pharmacol Ther (2010) 1.76
Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol (1998) 1.74
Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1. J Natl Cancer Inst (2001) 1.71
Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease. J Infect Dis (1994) 1.71
Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial. Circulation (1997) 1.70
Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization. J Clin Oncol (2001) 1.62
Spatial control of the gap gene knirps in the Drosophila embryo by posterior morphogen system. Science (1992) 1.59
Immune response to blood transfusion invery-low-birthweight infants. Transfusion (2000) 1.51
Serum Lp(a) concentrations are unaffected by treatment with the HMG-CoA reductase inhibitor Pravastatin: results of a 2-year investigation. Clin Chim Acta (1991) 1.47
Cyanopeptolins, new depsipeptides from the cyanobacterium Microcystis sp. PCC 7806. J Antibiot (Tokyo) (1993) 1.45
Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor. AIDS Res Hum Retroviruses (1994) 1.45
Effect of long-term dietary protein intake on glucose metabolism in humans. Diabetologia (2000) 1.45
Long-term results after video-assisted thoracoscopic surgery for first-time and recurrent spontaneous pneumothorax. Ann Thorac Surg (2000) 1.45
Carbohydrate-deficient transferrin is not a useful marker for the detection of chronic alcohol abuse. Eur J Clin Invest (1998) 1.42
The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer. Ann Oncol (2007) 1.42
CYFRA 21-1. A new marker in lung cancer. Cancer (1993) 1.42
[To resuscitate or not? The emergency physician's decision in the prehospital setting]. Anasthesiol Intensivmed Notfallmed Schmerzther (2003) 1.40
Chronic work stress is associated with atherogenic lipids and elevated fibrinogen in middle-aged men. J Intern Med (1997) 1.38
Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. Ann Oncol (2006) 1.37
[Is the alcoholic really sober, does the applicant drink, can the pilot still fly? CDT test often fails in reliability!]. MMW Fortschr Med (2000) 1.37
Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.36
Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer. Breast (2005) 1.35
Late relapse of germ cell tumors after cisplatin-based chemotherapy. Ann Oncol (1997) 1.33
A simple specific method for precipitation of low density lipoproteins. J Lipid Res (1983) 1.33
Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Anticancer Res (2001) 1.33
Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). J Lipid Res (1985) 1.33
Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J Lipid Res (2000) 1.25
CA19-9: a pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin. Anticancer Res (1999) 1.24
Renal complications in acute leukemias. Haematologica (1998) 1.23
Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients. J Natl Cancer Inst (1998) 1.20
Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer. Ann Oncol (2000) 1.17
Nucleosomes in serum as a marker for cell death. Clin Chem Lab Med (2001) 1.17
Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin? Onkologie (2003) 1.17
Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group. Transfusion (1994) 1.17
Distribution and phylogenetic significance of 27-hydroxy-octacosanoic acid in lipopolysaccharides from bacteria belonging to the alpha-2 subgroup of Proteobacteria. Int J Syst Bacteriol (1991) 1.16
Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer. Gynecol Oncol (2000) 1.16
Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion (1993) 1.15
Prevalence and patterns of morbidity among adults in Germany. Results of the German telephone health interview survey German Health Update (GEDA) 2009. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2012) 1.14
Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest (1994) 1.12
Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients. Eur J Cancer (2013) 1.12
Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br J Cancer (1994) 1.11
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44). Ann Oncol (2013) 1.09
Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor. Klin Wochenschr (1988) 1.09
Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivity. Anticancer Drugs (1996) 1.09
Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases. Anticancer Res (1999) 1.09
Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. Biol Chem Hoppe Seyler (1987) 1.08
Serum CEA and CA 15-3 as prognostic factors in primary breast cancer. Br J Cancer (2002) 1.08
Early signs of lung fibrosis after in vitro treatment of rat lung slices with CdCl2 and TGF-beta1. Histochem Cell Biol (2004) 1.07
Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression. Br J Cancer (1999) 1.07
Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial. Br J Cancer (2006) 1.07
Resection of hypernephromas with vena caval or right atrial tumor extension using extracorporeal circulation and deep hypothermic circulatory arrest: a multidisciplinary approach. Eur J Cardiothorac Surg (1997) 1.06
Apoptotic markers in cancer. Clin Biochem (2004) 1.05
Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer. J Clin Oncol (1998) 1.04
Conserved amino acid sequence of a neuropeptide, the head activator, from coelenterates to humans. Nature (1981) 1.04
Frequency of BRCA1 mutation 5382insC in German breast cancer patients. Gynecol Oncol (1999) 1.04
A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins. J Clin Invest (1970) 1.04
Incidence rates of fatal and nonfatal myocardial infarction in relation to the lipoprotein profile: first prospective results from the Göttingen Risk, Incidence, and Prevalence Study (GRIPS). Klin Wochenschr (1988) 1.04
Detection of HIV-1 in alternative specimen types using the APTIMA HIV-1 RNA Qualitative Assay. J Virol Methods (2009) 1.03
Hypertriglyceridaemia secondary to liver disease. Eur J Clin Invest (1974) 1.01
Transforming growth factor-beta1 induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells. FEBS Lett (1997) 1.01
Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL. Atherosclerosis (1989) 1.01
Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer. Clin Cancer Res (2001) 1.01
Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP). Eur J Clin Invest (1989) 1.00
Immunohistochemical profiles of 30 monoclonal antibodies against cytokeratins 8, 18 and 19. Second report of the TD5 workshop. Tumour Biol (2000) 1.00
Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group. J Clin Oncol (1998) 1.00
Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer. Ann Oncol (2001) 1.00
Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop. Tumour Biol (1998) 0.99
An improved microcomputer program for finding gene- or gene family-specific oligonucleotides suitable as primers for polymerase chain reactions or as probes. Comput Appl Biosci (1991) 0.99
Circulating nucleosomes in serum. Ann N Y Acad Sci (2001) 0.99